Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Jean Claude, BENSA"'
Autor:
Jacqueline Poulet, Marie-Christine Jacob, Eric Deconinck, Christophe Ferrand, Emilienne Kuhlein, Pierre Tiberghien, Jean-Claude Bensa, Françoise Schillinger, Bernard Drenou, Sabeha Biichle, Patrick Darodes de Tailly, Laurence Chaperot, Jean-Paul Remy-Martin, Véronique Salaun, Francine Garnache-Ottou, Estelle Seilles, Bénédicte Bulabois, Joel Plumas, Philippe Saas, Michel Arock
Publikováno v:
Blood
Blood, American Society of Hematology, 2005, 105 (3), pp.1256-64. ⟨10.1182/blood-2004-06-2416⟩
Blood, 2005, 105 (3), pp.1256-64. ⟨10.1182/blood-2004-06-2416⟩
Blood, American Society of Hematology, 2005, 105 (3), pp.1256-64. ⟨10.1182/blood-2004-06-2416⟩
Blood, 2005, 105 (3), pp.1256-64. ⟨10.1182/blood-2004-06-2416⟩
A new entity of acute leukemia coexpressing CD4(+)CD56(+) markers without any other lineage-specific markers has been identified recently as arising from lymphoid-related plasmacytoid dendritic cells (pDCs). In our laboratory, cells from a patient wi
Autor:
Christophe Caux, Nathalie Bendriss-Vermare, Marie-Christine Jacob, Joel Plumas, Béatrice Vanbervliet, Jean-Claude Bensa, Laurence Chaperot, Michel Peoc'h, Francine Brière
Publikováno v:
Leukemia
Leukemia, Springer Nature, 2004, 18 (9), pp.1491-8. ⟨10.1038/sj.leu.2403452⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2004, 18 (9), pp.1491-8. ⟨10.1038/sj.leu.2403452⟩
Leukemia, Springer Nature, 2004, 18 (9), pp.1491-8. ⟨10.1038/sj.leu.2403452⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2004, 18 (9), pp.1491-8. ⟨10.1038/sj.leu.2403452⟩
International audience; Plasmacytoid dendritic cell (PDC) leukemia/lymphoma is a rare neoplasm presenting cutaneous lesions at the time of diagnosis, followed by dissemination to bone marrow, lymph nodes, and other lymphoid and nonlymphoid organs. Si
Autor:
Alicia Lajmanovich, Marie-Anne Pasquier, Joel Plumas, Dominique Leroux, Magdalena Irisarri, Jean-Paul Molens, Jean-Jacques Sotto, Jean-Claude Bensa
Publikováno v:
British Journal of Haematology. 124:746-753
Multiple mechanisms exist by which tumour cells can escape CD95-mediated apoptosis. Previous studies by our laboratory have shown that primary B cells from non-Hodgkin's Lymphoma (B-NHL) were resistant to CD95-induced cell death. In the current study
Autor:
Véronique Salaun, Joel Plumas, Francine Brière, Jean-Claude Bensa, Laurence Chaperot, Ivan Perrot, D Blanchard, Marie-Christine Jacob, Véronique Deneys, Serge Lebecque
Publikováno v:
European Journal of Immunology. 34:418-426
This work aims to further characterize the newly described leukemic plasmacytoid dendritic cells (LPDC), for which we had previously demonstrated their normal, PDC-like ability to produce IFN-alpha. In addition, LPDC also express the specific antigen
Autor:
Joel Plumas, Jean-Claude Bensa, Marie-Christine Jacob, Laurence Chaperot, Jean-Jacques Sotto, Dominique Leroux, Agnès Moine, Jian Qing Mi, Jean-Paul Molens, Olivier Manches, Remy Gressin
Publikováno v:
British Journal of Haematology. 119:425-431
We have previously reported that specific anti-tumour cytotoxic T cells (CTL) can be differentiated from tumour-infiltrating lymphocytes (TIL) in non-Hodgkin's lymphoma. We found that the combination of interleukin (IL)-1, IL-2 and IL-12 was very eff
Autor:
Marie-Christine Jacob, Jean-Claude Bensa, Joel Plumas, Laurence Chaperot, Olivier Manches, Jean-Paul Molens
Publikováno v:
Leukemia & Lymphoma. 38:247-263
The question of the immunogenicity of non-Hodgkin's lymphoma (NHL) B cells has been investigated in an attempt to support the development of new immunotherapeutic treatments for this disorder, which remains resistant to conventional treatments in mos
Autor:
Joel Plumas, Laurence Chaperot, Jean-Jacques Sotto, Jean-Claude Bensa, F Le Marc'Hadour, Remy Gressin, C Giroux, Marie-Christine Jacob, Favre M, Samir G. Agrawal
Publikováno v:
Leukemia. 13:1428-1433
The expression of five cellular adhesion molecules (CAMs), CD54, CD58, CD11a, CD29 and CD49d, was studied in 113 B cell non-Hodgkin's lymphomas (NHL) and in normal B cells from 12 control lymph nodes. Rather than reporting the percentage of positive
Autor:
Marie-Hélène Delfau-Larue, Joel Plumas, Marie-Christine Jacob, Jean-Claude Bensa, Remy Gressin, Jean-Jacques Sotto, Samir G. Agrawal, Jean-Paul Molens, Bernard Roussel, Laurence Chaperot, Jean-Pierre Farcet
Publikováno v:
Experimental Hematology. 27:1185-1193
The present study describes a new culture protocol allowing the activation and proliferation of autologous tumor infiltrating T lymphocytes (TIL), and the generation of antitumor specific CTL in non-Hodgkin's lymphoma (NHL). Cells from eight patients
Autor:
Marie-Christine Jacob, Jean-Paul Molens, Jean-Claude Bensa, Jean-Jacques Sotto, Frédérique Bost, Laurence Chaperot, Joel Plumas
Publikováno v:
Experimental Hematology. 27:479-488
We analyzed the accessory function of malignant B cells from non-Hodgkin's lymphomas (NHLs). Among the 70 samples of malignant B cells included, four patterns of expression of the costimulatory molecules CD80 and CD86 were distinguished (+/+, +/-, -/
Autor:
Jean-Jacques Sotto, Marie-Christine Jacob, Jean-Claude Bensa, Jean-Paul Molens, Joel Plumas, Laurence Chaperot
Publikováno v:
Blood. 91:2875-2885
Apoptosis mediated by the CD95 (Fas/Apo-1) molecule plays a crucial role in the regulation of the B-cell immune response. In this study, we examined the function of the CD95 antigen in B-cell–derived non-Hodgkin's lymphoma (NHL), a malignant diseas